HealthInvest Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.2M | Buy |
38,721
+4,119
| +12% | +$3.21M | 12.92% | 1 |
|
|
2025
Q1 | $28.6M | Sell |
34,602
-2,466
| -7% | -$2.04M | 12.62% | 1 |
|
|
2024
Q4 | $28.7M | Buy |
37,068
+6,504
| +21% | +$5.03M | 13.6% | 1 |
|
|
2024
Q3 | $27.1M | Buy |
30,564
+3,420
| +13% | +$3.03M | 12.73% | 1 |
|
|
2024
Q2 | $24.6M | Buy |
27,144
+6,366
| +31% | +$5.76M | 14.98% | 1 |
|
|
2024
Q1 | $16.2M | Buy |
20,778
+4,973
| +31% | +$3.87M | 9.84% | 2 |
|
|
2023
Q4 | $9.21M | Buy |
+15,805
| New | +$9.21M | 7.21% | 2 |
|
|
2022
Q4 | $123K | Buy |
+335
| New | +$123K | 0.24% | 14 |
|
|
2017
Q4 | $2.7M | Buy |
+32,000
| New | +$2.7M | 5.7% | 13 |
|